News
The Lily Foundation celebrates approval of first ever mitochondrial disease treatment by NICE
The Lily Foundation, the UK’s leading mitochondrial disease charity, is today celebrating a landmark achievement in the fight against the disease – the first ever treatment for a mitochondrial condition has been approved for use on the NHS in England....
Seeing with fresh eyes: Snails as a system for studying sight restoration
Stowers scientists have established the apple snail as a new research organism for investigating eye regeneration, which may hold the key for restoring vision due to damage and disease. Snails are slimy, simple creatures yet one species, the apple snail,...
Glaucoma UK announces the recipients of its 2025 project grants
Glaucoma UK is delighted to announce the three recipients of our 2025 project grants. The panel had a difficult time deciding between some strong applications. The recipients are: Associate Professor Kuang Hu, at UCL Institute of Ophthalmology. His project is...
Early detection key to improving treatment of uveitis, a leading cause globally of vision loss
New treatment guidance has been developed to help doctors tackle uveitis — one of the leading causes of vision loss. The new clinical guidance, by a team at the University of Bristol, aims to help thousands of sufferers keep this...
Major grant secured to transform immune cell imaging research
A research team has been awarded significant funding by the National Institute for Health and Care Research (NIHR) to develop an innovative drug-device combination that aims to revolutionise how individual immune cells are monitored and treated in patients at Moorfields...
On Retina UK's behalf... Grant Call - Application Deadline Extension
Further to their letter of November 2024, Retina UK is extending the deadline for expressions of interest / preliminary applications to their first grant call for an award of up to £1 million. The call forms a key element of...
Worshipful Company of Spectacle Makers awards silver medal to Professor Robert Maclaren
At a Court Lunch held in the historic Apothecaries’ Hall last week, the Worshipful Company of Spectacle Makers awarded its prestigious Silver (Fincham) Medal to Professor Robert MacLaren. Professor MacLaren is Professor of Ophthalmology at the University of Oxford, Consultant...
Large-scale study uncovers demographic and sex factors behind genetic cause of age-related visual loss
A new study has identified a major genetic contributor to Fuchs’ Endothelial Corneal Dystrophy (FECD), a common cause of vision loss, also highlighting the significant roles of sex and ancestry. FECD is a common, inherited eye condition that primarily affects...
Major survey calls for new ideas on how to reinvent post diagnostic support for blind and partially sighted people
The Royal National Institute of Blind People (RNIB) is launching a new research study to better understand post-diagnostic support across the sight loss sector. People who have experienced being diagnosed with a sight condition know it’s not always easy to...
Novel retinal pigment metric tackles bias in AI models
Researchers have developed an innovative metric for objectively classifying pigmentation in a retinal image, rather than using subjective social constructs like ethnicity or other demographic variables, as is currently the case when building health datasets. Called the Retinal Pigment Score...
Genetic therapy gives infants life-changing improvements in sight
Four young children have gained life-changing improvements in sight following treatment with a pioneering new genetic medicine through Moorfields Eye Hospital and UCL Institute of Ophthalmology, with the support of MeiraGTx. The children were born with a severe impairment to...
New AI in ophthalmology resource goes live
The Royal College of Ophthalmologists has launched a new free resource, sharing and signposting artificial intelligence as medical device (AIaMD) tools for use in ophthalmology. The online AI directory is an evolving catalogue of AIaMD tools used in research or...
